| Acute hepatitis B/Akut hepatit B | 87 |
| Adverse events/Yan etkiler | 95 |
| ALT/ALT | 75 |
| Anesthesia/Anestezi | 15 |
| Anti-HBs titer/Anti-HBs titre | 70 |
| Anti-HBs/Anti-HBs | 10 |
| Anti-HCV/Anti-HCV | 52 |
| Anti-HDV/Anti-HDV | 1 |
| Anti-HIV/Anti-HIV | 119 |
| APRI/APRİ | 22, 81 |
| Attitude and practice/Tutum ve uygulama | 124 |
| Chronic HBV infection/Kronik HBV enfeksiyonu | 43 |
| Chronic HBV infection/Kronik hepatit B | 64 |
| Chronic hepatitis B/Kronik hepatit B | 22, 38, 75, 108, 114 |
| Chronic hepatitis C/Kronik hepatit C | 30, 95 |
| Cirrhosis/Siroz | 1 |
| COVID-19/COVID-19 | 30, 87 |
| Direct acting antivirals/Direkt etkili antiviraller | 58 |
| Direct-acting antiviral agents/Direkt etkili antiviral ajanlar | 95 |
| Direct-acting antiviral/Direkt-etkili antiviral | 90 |
| Direct-acting antivirals/Direkt etkili antiviraller | 101 |
| Direct-acting antivirals/Doğrudan etkili antiviraller | 81 |
| Drug resistance/İlaç direnci | 90 |
| Efficacy/Etkililik | 43 |
| Elimination/Eliminasyon | 30 |
| Entecavir/Entekavir | 38 |
| FIB-4/FIB-4 | 22, 81 |
| Fibrosis index/Fibrozis indeksi | 81 |
| Fibrosis score/Fibroz skoru | 75 |
| HAI score/HAİ skoru | 75 |
| HBV-DNA/HBV-DNA | 75 |
| HBV/HBV | 70 |
| HCV-genotype 1b/HCV-genotip 1b | 52 |
| HCV-RNA/HCV-RNA | 52 |
| HCV/HCV | 90 |
| HDV/HDV | 1 |
| Health care workers/Sağlık çalışanları | 124 |
| Hepatitis B vaccine/Hepatit B aşısı | 70 |
| Hepatitis B virus/Hepatit B virüsü | 38, 124 |
| Hepatitis B/Hepatit B | 119 |
| Hepatitis C treatment/Hepatit C tedavisi | 58 |
| Hepatitis C virus/Hepatitis C virüs | 30 |
| Hepatitis C/Hepatit C | 81, 90, 101, 119 |
| Hepatitis E/Hepatit E | 36 |
| Hepatitis/Hepatit | 1, 15 |
| Human health/İnsan sağlığı | 36 |
| Interleukin-28B/İnterlökin-28B | 108 |
| Knowledge/Bilgi | 124 |
| Lamivudine/Lamivudin | 38 |
| Liver biopsy/Karaciğer biyopsisi | 64 |
| Liver fibrosis/Karaciğer fibrozisi | 64, 114 |
| Liver/Karaciğer | 1, 87 |
| Management/Yönetim | 30 |
| Non-invasive parameter/Noninvaziv fibrosis göstergeleri | 64 |
| Nucleos(t)ide analogs/Nükleoz(t)id analogları | 38 |
| Orthohepevirus C/Ortohepevirüs C | 36 |
| Pegylated interferon/Pegile interferon | 38 |
| Point Shear Wave elastography/Point Shear Wave elastografi | 114 |
| Pre-operative evaluation/Preoperatif değerlendirme | 15 |
| Prison/Cezaevi | 119 |
| Prisoner/Mahkum | 119 |
| Real-world data/Gerçek yaşam verileri | 58 |
| Rocahepevirus ratti/Rocahepevirüs ratti | 36 |
| Single nucleotide polymorphism/Tek nükleotid polimorfizmi | 108 |
| Sofosbuvir/velpatasvir/voxilaprevir/Sofosbuvir/velpatasvir/voxilaprevir | 58 |
| Sustained virologic response/Kalıcı virolojik yanıt | 95 |
| Tenofovir alafenamide/Tenofovir alafenamid | 43 |
| Tenofovir/Tenofovir | 38 |
| Treatment response/Tedavi yanıtı | 108 |
| Treatment/Tedavi | 22 |
| Turkey/Türkiye | 10 |
| Vaccination/Aşılama | 10 |
| Viral hepatitis/Viral hepatitler | 101 |
| Viral kinetics/viral kinetik | 101 |
| Viral load/Viral yük | 101 |